By www.reliablebusinessinsights.com
Global PET Radiopharmaceuticals Market Research Report 2023 Story
93
$ 2900
PET Radiopharmaceuticals Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Cardinal Health Inc. (U.S.) Mallinckrodt plc (Ireland) GE Healthcare (U.K.) Lantheus Medical Imaging, Inc. (U.S.) Bayer AG (Germany) Bracco Imaging S.p.A (Italy) Eczacibasi-Monrol Nuclear Products (Turkey) Nordion, Inc. (Canada) Advanced Accelerator Applications S.A. (France) IBA Molecular Imaging (Belgium)